Changes	changes	O	O	O	O
of	of	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
ATP	atp	CHEMICALS	O	OTHERS	I
affinities	affinities	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cardiac	cardiac	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
during	during	O	O	O	O
and	and	O	O	O	O
after	after	O	O	O	O
nitric	nitric	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
deficient	deficient	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
system	system	O	O	O	O
,	,	O	O	O	O
NO	no	O	O	O	O
is	is	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
regulation	regulation	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
variety	variety	O	O	O	O
of	of	O	O	O	O
functions	functions	O	O	O	O
.	.	O	O	O	O

Inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
NO	no	O	O	O	O
synthesis	synthesis	O	O	O	O
induces	induces	O	O	O	O
sustained	sustained	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
several	several	O	O	O	O
models	models	O	O	O	O
of	of	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
elevation	elevation	O	O	O	O
of	of	O	O	O	O
intracellular	intracellular	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
was	was	O	O	O	O
documented	documented	O	O	O	O
in	in	O	O	O	O
cardiac	cardiac	O	O	O	O
tissue	tissue	O	O	O	O
.	.	O	O	O	O

To	to	O	O	O	O
assess	assess	O	O	O	O
the	the	O	O	O	O
molecular	molecular	O	O	O	O
basis	basis	O	O	O	O
of	of	O	O	O	O
disturbances	disturbances	O	O	O	O
in	in	O	O	O	O
transmembraneous	transmembraneous	O	O	O	O
transport	transport	O	O	O	O
of	of	O	O	O	O
Na+	na+	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
studied	studied	O	O	O	O
the	the	O	O	O	O
response	response	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
to	to	O	O	O	O
NO-deficient	no-deficient	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
by	by	O	O	O	O
NO-synthase	no-synthase	O	O	O	O
inhibition	inhibition	O	O	O	O
with	with	O	O	O	O
40	40	O	O	O	O
mg/kg/day	mg/kg/day	O	O	O	O
N(G)-nitro-L-arginine	n(g)-nitro-l-arginine	O	O	O	O
methyl	methyl	O	O	O	O
ester	ester	O	O	O	O
(	(	O	O	O	O
L-NAME	l-name	O	O	O	O
)	)	O	O	O	O
for	for	O	O	O	O
4	4	O	O	O	O
four	four	O	O	O	O
weeks	weeks	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
4-week	4-week	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
L-NAME	l-name	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
systolic	systolic	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
SBP	sbp	O	O	O	O
)	)	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
36	36	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
weeks	weeks	O	O	O	O
after	after	O	O	O	O
terminating	terminating	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
SBP	sbp	O	O	O	O
recovered	recovered	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
value	value	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
activating	activating	O	O	O	O
the	the	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
with	with	O	O	O	O
its	its	O	O	O	O
substrate	substrate	O	O	O	O
ATP	atp	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
no	no	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
Km	km	O	O	O	O
and	and	O	O	O	O
Vmax	vmax	O	O	O	O
values	values	O	O	O	O
were	were	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
NO-deficient	no-deficient	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
activation	activation	O	O	O	O
with	with	O	O	O	O
Na+	na+	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
Vmax	vmax	O	O	O	O
remained	remained	O	O	O	O
unchanged	unchanged	O	O	O	O
,	,	O	O	O	O
however	however	O	O	O	O
the	the	O	O	O	O
K(Na	k(na	O	O	O	O
)	)	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
50	50	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
indicating	indicating	O	O	O	O
a	a	O	O	O	O
profound	profound	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
affinity	affinity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Na+-binding	na+-binding	O	O	O	O
site	site	O	O	O	O
in	in	O	O	O	O
NO-deficient	no-deficient	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
recovery	recovery	O	O	O	O
from	from	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
increased	increased	O	O	O	O
,	,	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
higher	higher	O	O	O	O
affinity	affinity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
ATP-binding	atp-binding	O	O	O	O
site	site	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
revealed	revealed	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
lowered	lowered	O	O	O	O
Km	km	O	O	O	O
value	value	O	O	O	O
for	for	O	O	O	O
ATP	atp	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
K(Na	k(na	O	O	O	O
)	)	O	O	O	O
value	value	O	O	O	O
for	for	O	O	O	O
Na+	na+	O	O	O	O
returned	returned	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
value	value	O	O	O	O
.	.	O	O	O	O

Inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
NO-synthase	no-synthase	O	O	O	O
induced	induced	O	O	O	O
a	a	O	O	O	O
reversible	reversible	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
depressed	depressed	O	DISEASE	OTHERS	I
Na+-extrusion	na+-extrusion	O	O	O	O
from	from	O	O	O	O
cardiac	cardiac	O	O	O	O
cells	cells	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
consequence	consequence	O	O	O	O
of	of	O	O	O	O
deteriorated	deteriorated	O	O	O	O
Na+-binding	na+-binding	O	O	O	O
properties	properties	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
recovery	recovery	O	O	O	O
of	of	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
values	values	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
extrusion	extrusion	O	O	O	O
of	of	O	O	O	O
Na+	na+	O	O	O	O
from	from	O	O	O	O
cardiac	cardiac	O	O	O	O
cells	cells	O	O	O	O
was	was	O	O	O	O
normalized	normalized	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
revealed	revealed	O	O	O	O
by	by	O	O	O	O
restoration	restoration	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
(Na	(na	O	O	O	O
,	,	O	O	O	O
K)-ATPase	k)-atpase	O	O	O	O
activity	activity	O	O	O	O
.	.	O	O	O	O

